Primary rhabdoid tumors are highly malignant, rare tumors occurring in the renal, extrarenal soft tissue or central nervous system. They have non-specific radiological features and present with several histological components that create a problem in differential diagnosis with other embryonal tumors. We report a rare case of malignant rhabdoid tumor of the retina that presented with clinical features like those of retinoblastoma.

  • Malignant rhabdoid tumors occur in the renal, extrarenal soft tissue and central nervous system.

  • Most of these tumors share inactivation of the SMARCB1/INI-1 gene on chromosome 22q.

  • Malignant rhabdoid tumors can rarely occur intraocularly as a primary tumor or as a metastasis from the kidney.

  • Overall, 2–3% of tumors with rhabdoid histology retain expression of the SMARCB1 protein on immunohistochemistry and do not display inactivating mutations in the gene.

A 4-year-old male child, born of non-consanguinity, was brought to the ophthalmology clinic by his parents with a history of noticing a white reflex in his left eye for 1 week. It was not associated with any redness, pain, squinting, or photophobia. There was no history of ocular trauma. He was born at term and was developmentally normal. The child was stable, and a systemic examination was unremarkable. Ocular examination showed orthotropia with a normal range of extraocular movements. A white reflex was noted in the left eye. His visual acuity was 6/9 in the right eye and perception of light with an inaccurate projection of rays in the left eye. The anterior segment examination was normal in the right eye. The left eye showed a normal anterior chamber with a briskly reacting pupil and leukocoria (Fig. 1a, b). The fundus examination was normal in the right eye and showed a yellowish mass with intrinsic vascularity, occupying the vitreous cavity and extending up to the posterior surface of the lens. The optic nerve and macula were not demarcated. An ultrasound B-scan showed a hyperechoic mass lesion occupying almost two thirds of the vitreous cavity extending from the retina to the anterior vitreous (almost touching the lens). Moderate- to high-intensity A-scan spikes were noted with hyperechoic foci inside the mass suggestive of calcification (Fig. 1c). The complete hemogram, chest X-ray, ultrasound abdomen, and whole-body positron emission tomography scan were within normal limits. A brain MRI showed a heterogeneously enhancing lesion involving the inferior quadrants of the left eye globe with no obvious extrascleral or optic nerve extension (Fig. 1d).

Fig. 1.

a Clinical photograph of the child showing leukocoria in the left eye. b Slit-lamp image showing a retrolental yellowish mass with intrinsic vascularity. c Ultrasound B scan showing a hyperechoic mass in the vitreous cavity with calcification. d Coronal and axial MRI scan showing a large intraocular tumor in the vitreous cavity.

Fig. 1.

a Clinical photograph of the child showing leukocoria in the left eye. b Slit-lamp image showing a retrolental yellowish mass with intrinsic vascularity. c Ultrasound B scan showing a hyperechoic mass in the vitreous cavity with calcification. d Coronal and axial MRI scan showing a large intraocular tumor in the vitreous cavity.

Close modal

The patient was provisionally diagnosed with group E retinoblastoma and underwent enucleation with orbital implantation under general anesthesia. Histopathology revealed nests and sheets of tumor cells with round to oval vesicular nuclei with fine chromatin, a few of them showing prominent nucleoli, and moderate to abundant pale eosinophilic cytoplasm. Mitotic figures were frequent, around 4–5 per 10 high-power field (Fig. 2a–d), and calcification was seen focally. On immunohistochemistry (IHC), the tumor cells were diffusely positive for vimentin, pan-cytokeratin, neuron-specific enolase, and CD99, focally positive for glial fibrillary acidic protein (GFAP), synaptophysin, chromogranin, and FLI-1, and negative for EMA, PR, and S100 (ruling out meningioma). The tumor cells showed retained expression of inactivation of the integrase interactor (INI-1) and the Ki-67 index was 12%. The overall histomorphological and immunohistochemical profile favored the possibility of an embryonal tumor with rhabdoid features (Fig. 3a–f). Genetic testing for SMARB1 and RB1 mutation were negative. A heterozygous missense variation in exon 9 of the GUCY2D (chromosome 17) was detected which did not correlate with the clinical findings. The child received six cycles of chemotherapy and is on regular follow-up with no evidence of residual tumor.

Fig. 2.

a Gross examination of the left eye enucleation specimen showed an exophytic, gray-white, solid tumor located in the vitreous cavity. b Scanner view photomicrograph revealed a tumor arising from the retinal layer of the eyeball. HE, ×40. c Tumor cells arranged in nests and sheets separated by delicate fibrovascular septae. HE, ×100. d Tumor cells exhibiting a rhabdoid morphology with eccentrically placed round nuclei, vesicular chromatin with intranuclear inclusions in some cells, and an abundant amount of bright eosinophilic cytoplasm. HE, ×400.

Fig. 2.

a Gross examination of the left eye enucleation specimen showed an exophytic, gray-white, solid tumor located in the vitreous cavity. b Scanner view photomicrograph revealed a tumor arising from the retinal layer of the eyeball. HE, ×40. c Tumor cells arranged in nests and sheets separated by delicate fibrovascular septae. HE, ×100. d Tumor cells exhibiting a rhabdoid morphology with eccentrically placed round nuclei, vesicular chromatin with intranuclear inclusions in some cells, and an abundant amount of bright eosinophilic cytoplasm. HE, ×400.

Close modal
Fig. 3.

On IHC, tumor cells were diffusely positive with vimentin (DAB, ×100; a) as well as CD99 (DAB, ×200; b). They were focally positive for IHC with synaptophysin (DAB, ×200; c) and GFAP (DAB, ×400; d). The cells showed retained expression of INI-1 (DAB, ×200; e) and were negative for desmin, EMA, and S100 (DAB, ×100; f).

Fig. 3.

On IHC, tumor cells were diffusely positive with vimentin (DAB, ×100; a) as well as CD99 (DAB, ×200; b). They were focally positive for IHC with synaptophysin (DAB, ×200; c) and GFAP (DAB, ×400; d). The cells showed retained expression of INI-1 (DAB, ×200; e) and were negative for desmin, EMA, and S100 (DAB, ×100; f).

Close modal

Malignant rhabdoid tumors are extremely aggressive childhood neoplasms that have a poor clinical prognosis and occur in the renal, extrarenal soft tissue location, and the central nervous system (atypical teratoid/rhabdoid tumor) [1]. The “rhabdoid” cells are large epithelioid cells with an eosinophilic cytoplasm, eccentric vesicular nuclei, prominent nucleoli, and globoid or fibrillar paranuclear inclusions corresponding ultra-structurally to whorled bundles of intermediate filaments [2].These tumors usually develop in infants and young children, occur sporadically or as part of rhabdoid tumor predisposition syndrome, and share inactivation of the SMARCB1/INI-1 gene on chromosome 22q (a classic tumor suppressor gene) [3, 4]. However, germline perturbations in SMARCB1 is estimated to occur only in approximately 25–30% of patients with malignant rhabdoid tumors and in our case there were no variations in the gene. The INI-1 expression was retained by the tumor nuclei, which is extremely unusual for this tumor type. In a study by Perry et al. [2], composite rhabdoid tumors derived secondarily from other tumor types like carcinoma, melanoma, sarcoma, or meningioma showed retained expression of INI-1. These are more common in adults, less aggressive, and the rhabdoid cytology represents a common end-stage pattern in these histogenetically diverse groups of tumors. Malignant rhabdoid tumor has been reported in the ocular region secondarily as an ocular metastasis from the renal tumor or primarily in the orbit, retina, and optic nerve [5-8].

MRI often shows an isointense or hypointense signal on T1- and T2-weighted images with areas of hemorrhage, calcification, necrosis, or edema [9]. The differential diagnosis includes medulloepitheliomas, primitive neuroectodermal, and germ cell tumors. Medulloepitheliomas arise in the ciliary body region, contain intratumoral cysts, and a histopathological appearance comprising of primitive neuroepithelial cells surrounded by a mucopolysaccharide-rich matrix. The presence of perinuclear cytoplasmic inclusions is usually more characteristic of rhabdoid tumors and eccentrically placed nuclei with prominent central nucleoli resembling rhabdomyoblasts, while the neoplastic cells show skeletal muscle differentiation in the form of cross-striations and strap cells in rhabdomyosarcoma. Malignant rhabdoid tumor shares some morphological features with those entities, but the presence of rhabdoid cells and IHC helps to establish the diagnosis. For treatment, there are no definitive guidelines for malignant rhabdoid tumors because of their rarity. However, it is based on surgical resection, chemotherapy, and radiotherapy [10].

Primary intraocular malignant rhabdoid tumors are overly aggressive embryonal tumors that can rarely mimic retinoblastoma. An accurate diagnosis is possible with their histomorphologic features and IHC. Neuroimaging to look for a synchronous or metachronous central nervous system tumor is essential.

The authors acknowledge the contribution of Dr. Amit Kumar Deb, Dr. Mary Stephen, Dr. Pragathi Sparsh, and Dr. Vishnu Nair in the clinical management of this patient.

Written informed consent for publication (including the images) has been obtained from the parent. All procedures carried out were in accordance with the tenets of the Declaration of Helsinki. Institutional ethics committee approval is not required for a case report according to the Indian council of medical research guidelines.

The authors declare no conflicts of interest for this case study.

Funding was received from CanKids fundraising organisation for the histopathological and molecular testing performed in this study.

N.K., P.G., G.P., and A.J. contributed to the patient evaluation, management, and follow-up. S.B.H. and V.R. provided the histopathological details. All authors contributed to the manuscript preparation and review.

1.
Biggs
PJ
,
Garen
PD
,
Powers
JM
,
Garvin
AJ
.
Malignant rhabdoid tumor of the central nervous system
.
Hum Pathol
.
1987
Apr
;
18
(
4
):
332
7
.
[PubMed]
0046-8177
2.
Perry
A
,
Fuller
CE
,
Judkins
AR
,
Dehner
LP
,
Biegel
JA
.
INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas
.
Mod Pathol
.
2005
Jul
;
18
(
7
):
951
8
.
[PubMed]
0893-3952
3.
Judkins
AR
,
Eberhart
CG
,
Wesseling
P
.
Atypical teratoid/rhabdoid tumour. World Health Organization Classification of tumours of the central nervous system
.
Lyon
:
IARC Press
;
2007
. pp.
147
9
.
4.
Sigauke
E
,
Rakheja
D
,
Maddox
DL
,
Hladik
CL
,
White
CL
 3rd
,
Timmons
CF
, et al
Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis
.
Mod Pathol
.
2006
May
;
19
(
5
):
717
25
.
[PubMed]
0893-3952
5.
Verma
A
,
Morriss
C
.
Atypical teratoid/rhabdoid tumor of the optic nerve
.
Pediatr Radiol
.
2008
Oct
;
38
(
10
):
1117
21
.
[PubMed]
0301-0449
6.
Shah
SJ
,
Ali
MJ
,
Mulay
K
,
Honavar
SG
,
Reddy
VA
.
Primary intraocular malignant extrarenal rhabdoid tumour: a clinicopathological correlation
.
J Pediatr Ophthalmol Strabismus
.
2013
Apr
;
•••
:
50
.0191-3913
7.
Ayala Barroso
E
,
Tapia Bahamondes
A
,
Sánchez España
JC
,
Alós
L
,
Medel Jiménez
R
.
Primary Intraocular Malignant Rhabdoid Tumor Without Extrascleral Compromise
.
J Pediatr Ophthalmol Strabismus
.
2018
Apr
;
55
:
e7
9
.
[PubMed]
0191-3913
8.
Mahdi
Y
,
Kharmoum
J
,
Alouan
A
,
Elouarradi
H
,
Elkhiyat
I
,
Maher
M
, et al
Primary atypical teratoid/rhabdoid tumor of the optic nerve: a rare entity in an exceptional location
.
Diagn Pathol
.
2015
May
;
10
(
1
):
47
.
[PubMed]
1746-1596
9.
Parmar
H
,
Hawkins
C
,
Bouffet
E
,
Rutka
J
,
Shroff
M
.
Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors
.
Pediatr Radiol
.
2006
Feb
;
36
(
2
):
126
32
.
[PubMed]
0301-0449
10.
Hada
M
,
Chawla
B
,
Seth
R
,
Khurana
S
,
Kashyap
S
.
Primary intraocular malignant rhabdoid tumor presenting as orbital mass with intracranial extension in an adolescent
.
Can J Ophthalmol
.
2017
Feb
;
52
(
1
):
e3
5
.
[PubMed]
0008-4182
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.